Oral Solid Dosage Contract Manufacturing Market is Expected to Reach a Valuation of US$ 40,776.0 Million by 2034 | Fact.MR Report
Rising Prevalence of Chronic Diseases Spurs Demand for Oral Solid Dosage Formulations, Compelling Market GrowthRockville, MD, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The global oral solid dosage contract ...
Hosted on MSN10d
Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World
Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s diseaseONAPGO is a wearable subcutaneous infusion ...